HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fangfang Chen Selected Research

Ovarian Neoplasms (Ovarian Cancer)

12/2023Integrated transcriptomic and proteomic analysis reveals Guizhi-Fuling Wan inhibiting STAT3-EMT in ovarian cancer progression.
1/2022The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer.
1/2021p53 Promoted Ferroptosis in Ovarian Cancer Cells Treated with Human Serum Incubated-Superparamagnetic Iron Oxides.
1/2021Detection of BRCA1/2 Mutation and Analysis of Clinicopathological Characteristics in 141 Cases of Ovarian Cancer.
8/2020Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fangfang Chen Research Topics

Disease

58Neoplasms (Cancer)
05/2024 - 01/2014
12Neoplasm Metastasis (Metastasis)
12/2023 - 01/2015
12Breast Neoplasms (Breast Cancer)
11/2021 - 03/2015
10Inflammation (Inflammations)
01/2024 - 10/2014
9Infections
05/2024 - 07/2014
7Colorectal Neoplasms (Colorectal Cancer)
04/2023 - 01/2017
6Carcinogenesis
04/2023 - 01/2019
5Hepatocellular Carcinoma (Hepatoma)
03/2024 - 01/2016
5Ovarian Neoplasms (Ovarian Cancer)
12/2023 - 08/2020
5Obesity
01/2023 - 06/2014
4Prostatic Neoplasms (Prostate Cancer)
05/2024 - 05/2017
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2023 - 12/2013
4Hypertension (High Blood Pressure)
01/2022 - 03/2015
4Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2018
3COVID-19
02/2024 - 01/2022
3Bites and Stings (Sting)
01/2024 - 10/2021
3Esophageal Squamous Cell Carcinoma
12/2023 - 01/2022
3Hypoxia (Hypoxemia)
12/2023 - 01/2019
3Rheumatoid Arthritis
10/2023 - 01/2020
3Testicular Neoplasms (Testicular Cancer)
04/2023 - 11/2021
3Insulin Resistance
05/2022 - 01/2019
3Overweight
05/2022 - 01/2016
3Colonic Neoplasms (Colon Cancer)
10/2021 - 01/2017
3Ischemia
01/2015 - 02/2010
2Communicable Diseases (Infectious Diseases)
05/2024 - 02/2024
2Pneumonia (Pneumonitis)
01/2024 - 01/2021
2Esophageal Neoplasms (Esophageal Cancer)
12/2023 - 01/2022
2Acquired Immunodeficiency Syndrome (AIDS)
03/2023 - 10/2015
2Squamous Cell Carcinoma of Head and Neck
01/2022 - 11/2021
2Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 12/2016
2Major Depressive Disorder (Major Depressive Disorders)
10/2021 - 09/2015
2Cognitive Dysfunction
04/2021 - 01/2015
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 01/2020
2Human Influenza (Influenza)
01/2021 - 04/2008
2Liver Neoplasms (Liver Cancer)
11/2020 - 09/2019
2Wounds and Injuries (Trauma)
04/2020 - 03/2019
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 06/2014
2Triple Negative Breast Neoplasms
01/2020 - 01/2020
2Proteinuria
01/2019 - 03/2015
2Glioma (Gliomas)
01/2019 - 01/2017

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
05/2024 - 01/2018
10Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
7Long Noncoding RNAIBA
01/2021 - 06/2015
6Messenger RNA (mRNA)IBA
08/2023 - 01/2021
5MethyltransferasesIBA
03/2024 - 01/2021
5EnzymesIBA
03/2023 - 01/2018
5MicroRNAs (MicroRNA)IBA
01/2021 - 11/2013
4AntigensIBA
04/2023 - 11/2021
4Glucose (Dextrose)FDA LinkGeneric
05/2022 - 04/2014
3FollistatinIBA
03/2024 - 01/2014
3Analgesics (Analgesic Drugs)IBA
03/2024 - 09/2010
3CytokinesIBA
01/2024 - 01/2016
3Cisplatin (Platino)FDA LinkGeneric
12/2023 - 03/2023
3RNA (Ribonucleic Acid)IBA
12/2023 - 09/2019
3itaconic acidIBA
12/2023 - 01/2022
3InterferonsIBA
11/2023 - 01/2022
3Methotrexate (Mexate)FDA LinkGeneric
10/2023 - 01/2020
36-methyladenineIBA
08/2023 - 01/2021
3Transcription Factors (Transcription Factor)IBA
10/2021 - 07/2016
3LipidsIBA
03/2021 - 04/2014
3Phenobarbital (Luminal)FDA Link
01/2021 - 01/2020
3ferric oxide (iron oxide)IBA
01/2021 - 11/2015
3LigandsIBA
11/2020 - 01/2015
3ChitosanIBA
04/2020 - 12/2014
3AlkaloidsIBA
01/2019 - 09/2014
3Indicators and Reagents (Reagents)IBA
01/2018 - 12/2014
2Docetaxel (Taxotere)FDA Link
05/2024 - 01/2023
2IonsIBA
05/2024 - 01/2022
2TriterpenesIBA
03/2024 - 02/2010
2IronIBA
12/2023 - 01/2021
2DNA (Deoxyribonucleic Acid)IBA
11/2023 - 07/2016
2Etanercept (Enbrel)FDA Link
10/2023 - 10/2023
2N-methyladenosineIBA
08/2023 - 01/2021
2RNA-Binding Proteins (RNA-Binding Protein)IBA
08/2023 - 01/2022
2SolutionsIBA
04/2023 - 01/2020
2Therapeutic UsesIBA
04/2023 - 01/2020
2Protamines (Protamine Sulfate)FDA Link
04/2023 - 11/2021
2MXeneIBA
10/2022 - 06/2022
2hydroxide ionIBA
01/2022 - 01/2022
2Bile Acids and Salts (Bile Acids)IBA
01/2022 - 11/2020
2Sirtuin 1IBA
01/2022 - 08/2020
2Tumor Biomarkers (Tumor Markers)IBA
11/2021 - 12/2014
2HDL CholesterolIBA
03/2021 - 01/2019
2Protein Kinases (Protein Kinase)IBA
01/2021 - 11/2015
2Metal-Organic FrameworksIBA
01/2021 - 04/2020
2SincalideFDA Link
01/2021 - 03/2019
2CateninsIBA
08/2020 - 01/2020
2Histone Deacetylases (Histone Deacetylase)IBA
01/2020 - 01/2014
2AndrogensIBA
01/2020 - 05/2017
2Complement System Proteins (Complement)IBA
03/2019 - 11/2015
2AdiponectinIBA
01/2019 - 01/2018
2OvalbuminIBA
01/2019 - 01/2016
2Chemokine ReceptorsIBA
01/2019 - 01/2018
2Bevacizumab (Avastin)FDA Link
01/2017 - 03/2015

Therapy/Procedure

18Therapeutics
04/2024 - 12/2014
7Drug Therapy (Chemotherapy)
05/2024 - 12/2013
5Immunotherapy
01/2023 - 11/2020
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2024 - 01/2015
2Precision Medicine
01/2022 - 01/2017
2Meditation
10/2021 - 09/2015